Time-to-diagnosis and symptoms of myeloma, lymphomas and leukaemias: a report from the Haematological Malignancy Research Network
Conclusions
Pathways to diagnosis are varied and can be unacceptably prolonged, particularly for myeloma and some lymphomas. More evidence is needed, along with interventions to reduce time-to-diagnosis, such as public education campaigns and GP decision-making aids, as well as refinement of existing Referral Guidelines.
Source: BMC Hematology - Category: Hematology Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Alcoholism | Bleeding | Cancer | Cancer & Oncology | Education | Emergency Medicine | Gastric (Stomach) Cancer | Hematology | HIV AIDS | Leukemia | Lymphoma | Myeloma | Pain | Primary Care | Universities & Medical Training